DEWA has surpassed its own previous world record of 0.94 minutes in 2024, representing an improvement of around 13 per cent ...

Global 4WARD Phase 3 Chronic Neutropenia Trial On Track to Complete Enrollment by the end of Q3 2026 - - European Commission Approval of XOLREMDI® (Mavorixafor) Provides the First and Only Authorized ...